SHC · Sotera Health Company
$17.35
+3.02% last session
End-of-day data · updated 2026-07-28
Market cap
$5B
Enterprise value
$7B
Trailing P/E
42.1
Forward P/E
16.3
Dividend yield
—
Beta
1.77
Avg volume
3M
Employees
3K
2D change
—
5D change
-1.43%
10D change
-2.87%
30D change
-0.81%
60D change
10.23%
MTD change
-2.87%
YTD change
-2.27%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — SHC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-06-24
Latest call per bank · past 12 months
Barclays
Overweight$19.00
+9.5% vs priceGoldman Sachs
Buy$20.00
+15.3% vs priceCitigroup
Buy$23.00
+32.6% vs priceJP Morgan
Neutral$16.00
-7.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-06-24 | Barclays | Maintains | Overweight | $18.00 → $19.00 |
| 2026-06-05 | Goldman Sachs | Initiates | Buy | $0.00 → $20.00 |
| 2026-05-06 | Piper Sandler | Reiterates | Overweight | $24.00 → $22.00 |
| 2026-04-14 | Barclays | Maintains | Overweight | $20.00 → $18.00 |
| 2026-02-24 | Citigroup | Maintains | Buy | $21.00 → $23.00 |
| 2026-01-09 | Piper Sandler | Upgrade | Neutral → Overweight | $17.00 → $24.00 |
| 2025-12-18 | William Blair | Initiates | Outperform | $0.00 |
| 2025-11-13 | BMO Capital | Initiates | Outperform | $0.00 → $19.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 56 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 6.8% above the 50-day MA ($16.63).
- Price vs 200-day MA: Trading 8.0% above the 200-day MA ($16.44).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.13) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($11.06) and high ($19.35).
SHC Price Chart
Loading chart for SHC…
Fundamentals
About Sotera Health Company
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
More in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
$208B -3.3% YTD
DHR
Danaher Corporation
$138B -13.8% YTD
IDXX
IDEXX Laboratories, Inc.
$44B -17.8% YTD
A
Agilent Technologies, Inc.
$39B 1.9% YTD
NTRA
Natera, Inc.
$37B 12.6% YTD
IQV
IQVIA Holdings, Inc.
$36B -5.4% YTD
WAT
Waters Corporation
$36B -2.3% YTD
ILMN
Illumina, Inc.
$29B 44.5% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.